SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-23-000080
Filing Date
2023-11-09
Accepted
2023-11-09 16:00:38
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tars-20230930.htm   iXBRL 10-Q 1353062
2 EX-10.1 hercules_tarsus-secondamen.htm EX-10.1 42389
3 EX-31.1 exhibit311-93023.htm EX-31.1 9816
4 EX-31.2 exhibit312-93023.htm EX-31.2 10199
5 EX-32.1 exhibit321-93023.htm EX-32.1 6211
6 EX-32.2 exhibit322-93023.htm EX-32.2 6084
  Complete submission text file 0001819790-23-000080.txt   7292779

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20230930.xsd EX-101.SCH 45564
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20230930_cal.xml EX-101.CAL 77652
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20230930_def.xml EX-101.DEF 202167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20230930_lab.xml EX-101.LAB 612887
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20230930_pre.xml EX-101.PRE 399288
68 EXTRACTED XBRL INSTANCE DOCUMENT tars-20230930_htm.xml XML 1141596
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 231392120
SIC: 2836 Biological Products, (No Diagnostic Substances)